Profile | GDS4284 / 205220_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 934.347 | 73 |
GSM687648 | Patient 402 control | 3399.84 | 90 |
GSM687653 | Patient 403 control | 553.981 | 66 |
GSM687658 | Patient 404 control | 3814.95 | 91 |
GSM687663 | Patient 411 control | 3168.45 | 89 |
GSM687668 | Patient 422 control | 2824.66 | 88 |
GSM687673 | Patient 424 control | 4562.7 | 93 |
GSM687678 | Patient 425 control | 2888.78 | 88 |
GSM687683 | Patient 427 control | 1592.53 | 81 |
GSM687688 | Patient 428 control | 678.289 | 68 |
GSM687695 | Patient 441 control | 17930.6 | 98 |
GSM687699 | Patient 443 control | 2207.04 | 85 |
GSM687704 | Patient 444 control | 738.912 | 69 |
GSM687707 | Patient 448 control | 1377.73 | 79 |
GSM687712 | Patient 449 control | 565.64 | 65 |
GSM687719 | Patient 450 control | 4075.96 | 92 |
GSM687724 | Patient 451 control | 1021.2 | 75 |
GSM687728 | Patient 452 control | 12600.3 | 98 |
GSM687646 | Patient 401 treated 24h | 643.322 | 67 |
GSM687649 | Patient 402 treated 24h | 3215.9 | 89 |
GSM687665 | Patient 411 treated 24h | 3847.86 | 91 |
GSM687651 | Patient 402 treated 4 weeks | 2869.19 | 88 |
GSM687667 | Patient 411 treated 4 weeks | 2190.11 | 85 |
GSM687670 | Patient 422 treated 24h | 2687.19 | 88 |
GSM687671 | Patient 422 treated 4 weeks | 2275.71 | 85 |
GSM687654 | Patient 403 treated 24h | 963.982 | 74 |
GSM687675 | Patient 424 treated 24h | 5429.2 | 94 |
GSM687685 | Patient 427 treated 24h | 1450.75 | 79 |
GSM687656 | Patient 403 treated 4 weeks | 634.758 | 68 |
GSM687677 | Patient 424 treated 4 weeks | 2357.93 | 86 |
GSM687687 | Patient 427 treated 4 weeks | 1021.89 | 74 |
GSM687692 | Patient 428 treated 4h | 1128.88 | 76 |
GSM687716 | Patient 449 treated 4h | 535.841 | 65 |
GSM687722 | Patient 450 treated 4h | 4069.01 | 92 |
GSM687680 | Patient 425 treated 24h | 1825.52 | 82 |
GSM687690 | Patient 428 treated 24h | 1891.96 | 83 |
GSM687700 | Patient 443 treated 24h | 8363.09 | 97 |
GSM687705 | Patient 444 treated 24h | 1949.43 | 84 |
GSM687714 | Patient 449 treated 24h | 923.812 | 73 |
GSM687721 | Patient 450 treated 24h | 7061.12 | 96 |
GSM687682 | Patient 425 treated 4 weeks | 2295.97 | 86 |
GSM687694 | Patient 428 treated 4 weeks | 1484.66 | 79 |
GSM687702 | Patient 443 treated 4 weeks | 1531.88 | 80 |
GSM687718 | Patient 449 treated 4 weeks | 511.228 | 64 |
GSM687723 | Patient 450 treated 4 weeks | 2682.9 | 87 |
GSM687661 | Patient 404 treated 4h | 4521.77 | 93 |
GSM687710 | Patient 448 treated 4h | 1322.47 | 79 |
GSM687726 | Patient 451 treated 4h | 1360.54 | 79 |
GSM687730 | Patient 452 treated 4h | 7646.71 | 96 |
GSM687660 | Patient 404 treated 24h | 26887.5 | 99 |
GSM687697 | Patient 441 treated 24h | 11506.8 | 97 |
GSM687709 | Patient 448 treated 24h | 2618.34 | 87 |
GSM687725 | Patient 451 treated 24h | 1540.47 | 81 |
GSM687729 | Patient 452 treated 24h | 27326.5 | 99 |
GSM687727 | Patient 451 treated 4 weeks | 1112.17 | 76 |
GSM687731 | Patient 452 treated 4 weeks | 8421.71 | 96 |